Perspectives in Clinical Research

LETTER TO EDITOR
Year
: 2015  |  Volume : 6  |  Issue : 2  |  Page : 120--121

Author's reply


Priya Ranganathan 
 Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India

Correspondence Address:
Dr. Priya Ranganathan
Department of Anaesthesiology, Critical Care and Pain, Tata Memorial Hospital, Parel, Mumbai - 400 012, Maharashtra
India




How to cite this article:
Ranganathan P. Author's reply.Perspect Clin Res 2015;6:120-121


How to cite this URL:
Ranganathan P. Author's reply. Perspect Clin Res [serial online] 2015 [cited 2021 Mar 6 ];6:120-121
Available from: https://www.picronline.org/text.asp?2015/6/2/120/154021


Full Text

Sir,

I thank the authors for their comments on my letter and for raising an interesting debate about the appropriate use of statistics for the testing of data related to pain scores especially the visual analog scale (VAS).

In an article by Akhavanakbari et al., [1] the abstract mentions the use of repeated-measures analysis of variance (ANOVA), whereas the methods section in the manuscript mentions the use of the ANOVA. It is unclear which of these two tests was actually applied. Pain scores (using the VAS) have been charted at various time-points: 6, 12, 24, 36, and 48 h following the intervention [Table 1 of the original publication] along with a "P0" value but there is no mention in the methods section about whether the "P" refers to a within-group change with time or a between-group comparison. In fact, this sentence in the results section "At the end of the study, the differences in VAS score and rate of drug consumption was statistically significant between patients in three groups" suggests that the analysis represents a between-group comparison rather than a within-group comparison and for this, repeated-measures ANOVA would not be appropriate.

The subject of whether VAS scores should be analyzed using parametric or nonparametric has been a matter of debate among statisticians. Kersten et al. [2] has suggested that it is inappropriate to use anything other than nonparametric analysis for this type of data; others like Price [3] and Harms-Ringdahl [4] have opposed this view. However, there seems to be no dispute that data distribution and sample size have to be taken into account when choosing statistical methods. [4] In this context and with a small sample size (60 patients), I feel it would have been more suitable for the authors to have checked the normality of data before adopting a parametric test.

References

1Akhavanakbari G, Mohamadian A, Entezariasl M. Evaluation the effects of adding ketamine to morphine in intravenous patient-controlled analgesia after orthopedic surgery. Perspect Clin Res 2014;5:85-7.
2Kersten P, Küçükdeveci AA, Tennant A. The use of the visual analogue scale (VAS) in rehabilitation outcomes. J Rehabil Med 2012;44:609-10.
3Price DD, Staud R, Robinson ME. How should we use the visual analogue scale (VAS) in rehabilitation outcomes? II: Visual analogue scales as ratio scales: An alternative to the view of Kersten et al. J Rehabil Med 2012;44:800-1.
4Harms-Ringdahl K. How should we use the visual analogue scale (VAS) in rehabilitation outcomes? III: On the validation requirements for assessments using VAS with ratio properties. J Rehabil Med 2012;44:801-2.